Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Twist Bioscience Corp (TWST)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Twist Bioscience's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
29.24 -1.44    -4.69%
31/12 - Closed. Currency in USD ( Disclaimer )
After Hours
28.00
-1.24
-4.24%
17:09:18 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 847,475
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 29.02 - 31.07
Twist Bioscience 29.24 -1.44 -4.69%

Twist Bioscience Corp Company Profile

 
Get an in-depth profile of Twist Bioscience Corp, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

989

Equity Type

ORD

Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels, primarily used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, the company provides synthetic SARS-CoV-2 RNA reference sequences as positive controls for the development of both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries used for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Contact Information

Address 681 Gateway Boulevard
South San Francisco, 94080
United States
Phone 800 719 0671
Fax -
Web www.twistbioscience.com

Top Executives

Name Age Since Title
Nelson C. Chan 60 2019 Independent Director
Xiaoying Mai 33 2018 Independent Director
Robert B. Chess 64 2014 Lead Independent Director
Jan Johannessen 65 2018 Independent Director
Keith L. Crandell 61 2013 Independent Director
Melissa A. Starovasnik 56 2021 Independent Director
Emily Marine Leproust 49 2013 Co-Founder, Chairman & CEO
Robert P. Ragusa 63 2016 Independent Director
William Charles Banyai 69 2013 Senior VP of Advanced Development, GM of Data Storage & Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

TWST Comments

Write your thoughts about Twist Bioscience Corp
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
David Corley
David Corley Nov 17, 2022 9:27PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Scorpion Capital calls twist a “ponzi like” scheme.https://scorpionreports.s3.us-east-2.amazonaws.com/TW1.pdf
Reply
1 0
Report
Jefri Saragih
Jefri Saragih Nov 17, 2022 9:27PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
what must we do?
Reply
0 0
Report
Patrick Zingg
Pad1001 Nov 17, 2022 9:27PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
sell
Reply
0 0
Report
Grant Hovhannisyan
Grant Hovhannisyan Nov 28, 2021 6:15PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
some hedge funds are manipulating this stock - very clear long-term resistance and support levels
Reply
2 3
Report
Andrius Naprušis
Andrius Naprušis Sep 08, 2021 9:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Does this stock have a potencial to grow?
Reply
3 1
Report
Grant Hovhannisyan
Grant Hovhannisyan Sep 08, 2021 9:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
yes it has a big potential, on one hand this is a biotech brick and mortor company offering wide range of products and services, on the other they are market disruptors with their novel dna/rna synthesis tech
Reply
1 1
Report
Andrius Naprušis
Andrius Naprušis Sep 08, 2021 9:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
if i good understand, institusion own 98%. ši it,s mean that big Ones believe in this stock
Reply
0 0
Report
RF RF
RF RF Sep 08, 2021 9:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Maybe - if you have enough bio companies you should be able to get a winner.
Reply
0 0
Report
Grant Hovhannisyan
Grant Hovhannisyan Jun 29, 2021 7:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
can't believed this stock is so unnoticed
Reply
4 2
Report
Grant Hovhannisyan
Grant Hovhannisyan Mar 09, 2021 3:28PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
everyone talks Invitae, while Twist silently jumped 20% without Katy Wood
Reply
4 0
Report
Francesco Lugli
Francesco Lugli Mar 09, 2021 3:28PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Without? You not on the daily email list?
Reply
0 0
Report
Grant Hovhannisyan
Grant Hovhannisyan Mar 09, 2021 3:28PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Francesco Lugli its their 5th position but at the time a posted it there were no news about twist from ark
Reply
0 0
Report
Grant Hovhannisyan
Grant Hovhannisyan Feb 22, 2021 11:10AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Twist Bioscience, Berry Genomics Partner on Targeted NGS Assays in China
Reply
2 1
Report
Bon Anantasit
Bon Anantasit Feb 08, 2021 1:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
🚀🚀
Reply
0 2
Report
Bon Anantasit
Bon Anantasit Feb 07, 2021 12:32PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
im in...
Reply
2 0
Report
ccc sen
crazy22 Feb 05, 2021 10:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
In $157
Reply
3 1
Report
Grant Hovhannisyan
Grant Hovhannisyan Feb 05, 2021 10:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
me too
Reply
0 0
Report
ccc sen
crazy22 Feb 05, 2021 10:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
can anybody ventilate TWST?
Reply
0 0
Report
Max Action
Max Action Feb 05, 2021 10:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
lucky bast**d, i lost 40grand today but am long on this stock. i believe this stock will triple in value i don't care what the experts say.
Reply
0 1
Report
Peter Smith
Peter Smith Jan 08, 2021 10:51AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
He also mentions the surge in interest in electric-vehicle makers like Tesla Inc. TSLA, +7.94% as evidence of the market’s speculative fervor. “The most impressive features are the intensity and enthusiasm of bulls, the breadth of coverage of stocks and the market, and, above all, the rising hostility toward bears,” he writes.  https://www.marketwatch.com/story/famed-investor-doubling-down-says-stock-market-a-real-humdinger-of-a-bubble-11609882369?siteid=yhoof2
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email